Mohammed A Rashid1, Sophie Lovick2, Nadia R Llanwarne3. 1. UCL Medical School, London, UK. 2. School of Clinical Medicine, University of Cambridge, Cambridge, UK. 3. Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Abstract
Background: Although attention deficit hyperactivity disorder (ADHD) is a common condition for which pharmacotherapy is considered an effective treatment, guidelines on the treatment of ADHD have been challenging to implement. Considering the views of patients and caregivers involved in medication-taking could help shed light on these challenges. Objective: This review combines the findings of individual studies of medication-taking experiences in ADHD in order to guide clinicians to effectively share decisions about treatment. Methods: Five databases (MEDLINE, Embase, PsycINFO, SCOPUS and CINAHL) were systematically searched for relevant published research articles. Articles were assessed for quality using a Critical Appraisal Skills Programme checklist, and synthesis was performed using meta-ethnography. Results: Thirty-one articles were included in the final synthesis, comprising studies of caregivers, paediatric patients and adult patients across seven countries. Findings were categorized into five different constructs, including coming to terms with ADHD, anticipated concerns about medication, experiences of the effects of medication, external influences and the development of self-management. The synthesis demonstrates that decisions surrounding medication-taking for ADHD evolve as the child patient enters adulthood and moves towards autonomy and self-management. In all parts of this journey, decisions are shaped by a series of 'trade-offs', where potential benefits and harms of medication are weighed up. Conclusions: This review offers a comprehensive insight into medication-taking experiences in ADHD. By considering the shifting locus of decision-making over time and the need for individuals and families to reconcile a variety of external influences, primary care and mental health clinicians can engage in holistic conversations with their patients to share decisions effectively.
Background: Although attention deficit hyperactivity disorder (ADHD) is a common condition for which pharmacotherapy is considered an effective treatment, guidelines on the treatment of ADHD have been challenging to implement. Considering the views of patients and caregivers involved in medication-taking could help shed light on these challenges. Objective: This review combines the findings of individual studies of medication-taking experiences in ADHD in order to guide clinicians to effectively share decisions about treatment. Methods: Five databases (MEDLINE, Embase, PsycINFO, SCOPUS and CINAHL) were systematically searched for relevant published research articles. Articles were assessed for quality using a Critical Appraisal Skills Programme checklist, and synthesis was performed using meta-ethnography. Results: Thirty-one articles were included in the final synthesis, comprising studies of caregivers, paediatric patients and adult patients across seven countries. Findings were categorized into five different constructs, including coming to terms with ADHD, anticipated concerns about medication, experiences of the effects of medication, external influences and the development of self-management. The synthesis demonstrates that decisions surrounding medication-taking for ADHD evolve as the childpatient enters adulthood and moves towards autonomy and self-management. In all parts of this journey, decisions are shaped by a series of 'trade-offs', where potential benefits and harms of medication are weighed up. Conclusions: This review offers a comprehensive insight into medication-taking experiences in ADHD. By considering the shifting locus of decision-making over time and the need for individuals and families to reconcile a variety of external influences, primary care and mental health clinicians can engage in holistic conversations with their patients to share decisions effectively.
Authors: Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser Journal: Pediatrics Date: 2011-10-16 Impact factor: 7.124
Authors: Vanja Sikirica; Emuella Flood; C Noelle Dietrich; Javier Quintero; Val Harpin; Paul Hodgkins; Klaus Skrodzki; Kathleen Beusterien; M Haim Erder Journal: Patient Date: 2015-06 Impact factor: 3.883
Authors: I C K Wong; P Asherson; A Bilbow; S Clifford; D Coghill; R DeSoysa; C Hollis; S McCarthy; M Murray; C Planner; L Potts; K Sayal; E Taylor Journal: Health Technol Assess Date: 2009-10 Impact factor: 4.014
Authors: Catherine C Davis; Milena Claudius; Lawrence A Palinkas; John B Wong; Laurel K Leslie Journal: J Atten Disord Date: 2011-10-05 Impact factor: 3.256
Authors: Kerry K W Cheung; Ian C K Wong; Patrick Ip; Phyllis K L Chan; Candy H Y Lin; Lisa Y L Wong; Esther W Chan Journal: BMC Psychiatry Date: 2015-05-01 Impact factor: 3.630